Tag: development

A series of events in and around Norfolk, Nebraska—the midpoint of America's first cross-country multiuse trail—elevate magnitude of outdoor recreation's role in nation's well-beingWASHINGTON,...

TSX: TVECALGARY, AB, June 16, 2026 /CNW/ - Tamarack Valley Energy Ltd. has successfully closed the previously announced sale of its Charlie Lake assets for...

JAKARTA, Indonesia, June 16, 2026 /PRNewswire/ -- OMOWAY announced the delivery of the world's first batch of OMO-X motorcycles in Indonesia on June 15....

Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing, to support its lead asset through Phase 3.

New Tyvek® innovation designed to support worker safety and comfort across ASEANBANGKOK, June 16, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it...

BEIJING, June 16, 2026 /PRNewswire/ -- A report from China Daily ...

MUNICH, June 16, 2026 /PRNewswire/ -- Innovative Molecules GmbH ("IM"), a clinical-stage biopharmaceutical company focused on herpesvirus-mediated diseases, today announced the advancement of its virology...

SHENZHEN, China, June 16, 2026 /PRNewswire/ -- Shell Recharge and SINEXCEL (300693.SZ) officially signed a Memorandum of Understanding (MoU) and inaugurated the Shell Recharge–SINEXCEL Joint...

SHENZHEN, China, June 16, 2026 /PRNewswire/ -- Shell Recharge and SINEXCEL (300693.SZ) officially signed a Memorandum of Understanding (MoU) and inaugurated the Shell Recharge–SINEXCEL Joint...

Starting 16th June, L50s Pro Ultra and L50 Ultra CE will be available on Amazon India, Dreame Technology India website, Croma, and select retail...

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.